Cargando…
Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats
Coptidis Rhizoma (CR), the rhizome of Coptis chinensis FRANCH, is a popular Chinese herb. CR contains plenty of isoquinoline alkaloids such as berberine, coptisine and palmatine. Cyclosporine (CSP), an important immunosuppressant with narrow therapeutic window, is employed as a probe substrate of P-...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326880/ https://www.ncbi.nlm.nih.gov/pubmed/29703381 http://dx.doi.org/10.1016/j.jfda.2017.11.005 |
_version_ | 1784757388346130432 |
---|---|
author | Yu, Chung-Ping Huang, Ching-Ya Lin, Shiuan-Pey Hou, Yu-Chi |
author_facet | Yu, Chung-Ping Huang, Ching-Ya Lin, Shiuan-Pey Hou, Yu-Chi |
author_sort | Yu, Chung-Ping |
collection | PubMed |
description | Coptidis Rhizoma (CR), the rhizome of Coptis chinensis FRANCH, is a popular Chinese herb. CR contains plenty of isoquinoline alkaloids such as berberine, coptisine and palmatine. Cyclosporine (CSP), an important immunosuppressant with narrow therapeutic window, is employed as a probe substrate of P-glycoprotein (P-gp) and CYP3A4 in order to investigate the in vivo modulation effect of CR on P-gp and CYP3A4. Three groups of rats were orally administered CSP without and with single dose or repeated dosing of CR in a parallel design. Blood samples were collected at specific time points and the blood CSP concentration was determined by a specific monoclonal fluorescence polarization immunoassay. The results showed that a single dose (1.0 g/kg) and the 7th dose (1.0 g/kg) of CR significantly decreased the C(max) of CSP by 56.9% and 70.4%, and reduced the AUC(0-540) by 56.4% and 68.7%, respectively. Cell study indicated that CR decoction, berberine, coptisine, palmatine all activated the efflux transport of P-gp. Ex-vivo study showed that the serum metabolites of CR activated CYP 3A4. In conclusion, through using CSP as an in vivo probe substrate, we have verified that oral intake of CR activated the functions of P-gp and CYP3A based on in vivo and in vitro studies. |
format | Online Article Text |
id | pubmed-9326880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taiwan Food and Drug Administration |
record_format | MEDLINE/PubMed |
spelling | pubmed-93268802022-08-09 Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats Yu, Chung-Ping Huang, Ching-Ya Lin, Shiuan-Pey Hou, Yu-Chi J Food Drug Anal Original Article Coptidis Rhizoma (CR), the rhizome of Coptis chinensis FRANCH, is a popular Chinese herb. CR contains plenty of isoquinoline alkaloids such as berberine, coptisine and palmatine. Cyclosporine (CSP), an important immunosuppressant with narrow therapeutic window, is employed as a probe substrate of P-glycoprotein (P-gp) and CYP3A4 in order to investigate the in vivo modulation effect of CR on P-gp and CYP3A4. Three groups of rats were orally administered CSP without and with single dose or repeated dosing of CR in a parallel design. Blood samples were collected at specific time points and the blood CSP concentration was determined by a specific monoclonal fluorescence polarization immunoassay. The results showed that a single dose (1.0 g/kg) and the 7th dose (1.0 g/kg) of CR significantly decreased the C(max) of CSP by 56.9% and 70.4%, and reduced the AUC(0-540) by 56.4% and 68.7%, respectively. Cell study indicated that CR decoction, berberine, coptisine, palmatine all activated the efflux transport of P-gp. Ex-vivo study showed that the serum metabolites of CR activated CYP 3A4. In conclusion, through using CSP as an in vivo probe substrate, we have verified that oral intake of CR activated the functions of P-gp and CYP3A based on in vivo and in vitro studies. Taiwan Food and Drug Administration 2017-12-14 /pmc/articles/PMC9326880/ /pubmed/29703381 http://dx.doi.org/10.1016/j.jfda.2017.11.005 Text en © 2018 Taiwan Food and Drug Administration https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Original Article Yu, Chung-Ping Huang, Ching-Ya Lin, Shiuan-Pey Hou, Yu-Chi Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats |
title | Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats |
title_full | Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats |
title_fullStr | Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats |
title_full_unstemmed | Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats |
title_short | Activation of P-glycoprotein and CYP 3A by Coptidis Rhizoma in vivo: Using cyclosporine as a probe substrate in rats |
title_sort | activation of p-glycoprotein and cyp 3a by coptidis rhizoma in vivo: using cyclosporine as a probe substrate in rats |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326880/ https://www.ncbi.nlm.nih.gov/pubmed/29703381 http://dx.doi.org/10.1016/j.jfda.2017.11.005 |
work_keys_str_mv | AT yuchungping activationofpglycoproteinandcyp3abycoptidisrhizomainvivousingcyclosporineasaprobesubstrateinrats AT huangchingya activationofpglycoproteinandcyp3abycoptidisrhizomainvivousingcyclosporineasaprobesubstrateinrats AT linshiuanpey activationofpglycoproteinandcyp3abycoptidisrhizomainvivousingcyclosporineasaprobesubstrateinrats AT houyuchi activationofpglycoproteinandcyp3abycoptidisrhizomainvivousingcyclosporineasaprobesubstrateinrats |